연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1801. Targeting Phosphatidylinositol 4-Kinase IIIα for Radiosensitization: A Potential Model of Drug Repositioning Using an Anti-Hepatitis C Viral Agent.
Kwon J, Kim DH, Park JM, Park YH, Hwang YH, Wu HG, Shin KH, Kim IA.
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):867-876. doi: 10.1016/j.ijrobp.2016.08.007. Epub 2016 Aug 20.
Link
1800. Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells.
Yu T, Cho BJ, Choi EJ, Park JM, Kim DH, Kim IA
Oncotarget. 2016 Oct 12. doi: 10.18632/oncotarget.12597. [Epub ahead of print]
Link
1799. Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo.
Han TJ, Cho BJ, Choi EJ, Kim DH, Song SH, Paek SH, Kim IA.
J Neurooncol. 2016 Oct;130(1):89-98. Epub 2016 Aug 10.
Link
1798. MicroRNA-203 Modulates the Radiation Sensitivity of Human Malignant Glioma Cells.
Chang JH, Hwang YH, Lee DJ, Kim DH, Park JM, Wu HG, Kim IA.
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):412-20. doi: 10.1016/j.ijrobp.2015.10.001. Epub 2015 Oct 9.
Link
1797. Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization.
Kim JH, Moon SH, No M, Kim JJ, Choi EJ, Cho BJ, Kim JS, Kim IH, Kim IA.
Cancer Res Treat. 2016 Jul;48(3):1130-40. doi: 10.4143/crt.2015.206. Epub 2015 Nov 17.
Link
1796. Clinical significance of midkine expression in sporadic desmoid tumors.
Kim HS, Kim J, Nam KH, Kim WH.
Oncol Lett. 2016 Mar;11(3):1677-1684. Epub 2016 Jan 19.
Link
1795. Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.
Keam BS, Kim MK, Choi Y, Choi SJ, Choe PG, Lee KH, Kim TM, Kim TY, Oh DY, Kim DW, Im SA, Kim NJ, Heo DS, Park WB, Oh MD.
Cancer. 2016 Dec 20. doi: 10.1002/cncr.30468. [Epub ahead of print]
Link
1794. Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma.
Kim R, Keam BS, Kwon D, Ock CY, Kim M, Kim TM, Kim HJ, Jeon YK, Park IK, Kang CH, Kim DW, Kim YT, Heo DS.
World J Gastroenterol. 2016 Oct 7;22(37):8389-8397.
Link
1793. Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.
Lee DW, Lee KH, Kim JW, Keam BS.
Int J Mol Sci. 2016 Jul 5;17(7). pii: E1074. doi: 10.3390/ijms17071074.
Link
1792. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY, Keam BS, Kim TM, Han DH, Won TB, Lee SH, Hah JH, Kwon TK, Kim DW, Kim DY, Rhee CS, Wu HG, Sung MW, Heo DS.
Korean J Intern Med. 2016 May;31(3):570-8. doi: 10.3904/kjim.2015.020. Epub 2016 Mar 15.
Link